David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
CALL
AngloGold Ashanti
AU
$60.9B
| $228K | ﹤0.01% |
10,200
| – | – |
|
3702
PUT
HEICO Corp
HEI
$49.3B
| $228K | ﹤0.01% |
2,000
| – | – |
|
3703
Movado Group
MOV
$772M
| $228K | ﹤0.01% |
10,487
+561
| +6% | +$13.1K |
|
|
AERI
3704
DELISTED
Aerie Pharmaceuticals
AERI
| $228K | ﹤0.01% |
9,438
-137,331
| -94% | -$2.84M |
|
3705
CALL
Macerich
MAC
$6.91B
| $226K | ﹤0.01% |
+8,400
| New | +$231K |
|
3706
Tootsie Roll Industries
TR
$3.11B
| $226K | ﹤0.01% |
8,133
-8,347
| -51% | -$236K |
|
3707
Travelers Companies
TRV
$77.3B
| $226K | ﹤0.01% |
+1,650
| New | +$225K |
|
|
TPC
3708
Tutor Perini Cor
TPC
$4.64B
| $226K | ﹤0.01% |
+17,553
| New | +$271K |
|
3709
Caleres
CAL
$459M
| $225K | ﹤0.01% |
9,472
-51,666
| -85% | -$1.17M |
|
3710
PUT
Pan American Silver
PAAS
$22.2B
| $225K | ﹤0.01% |
+9,500
| New | +$176K |
|
|
FONR
3711
DELISTED
Fonar
FONR
| $224K | ﹤0.01% |
+11,357
| New | +$228K |
|
|
BVH
3712
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $224K | ﹤0.01% |
9,405
-529
| -5% | -$12.2K |
|
|
FL
3713
CALL
DELISTED
Foot Locker
FL
| $222K | ﹤0.01% |
5,700
-1,900
| -25% | -$80K |
|
3714
CALL
Bath & Body Works
BBWI
$3.86B
| $221K | ﹤0.01% |
15,091
| – | – |
|
3715
CorMedix
CRMD
$645M
| $221K | ﹤0.01% |
+30,306
| New | +$185K |
|
3716
Murphy Oil
MUR
$5.16B
| $220K | ﹤0.01% |
+8,200
| New | +$188K |
|
3717
NETGEAR
NTGR
$563M
| $220K | ﹤0.01% |
8,979
-7,805
| -47% | -$213K |
|
|
CPE
3718
DELISTED
Callon Petroleum Company
CPE
| $220K | ﹤0.01% |
4,548
+1,803
| +66% | +$74.6K |
|
3719
NexGen Energy
NXE
$7.33B
| $219K | ﹤0.01% |
170,100
+131,800
| +344% | +$169K |
|
3720
ResMed
RMD
$33.5B
| $219K | ﹤0.01% |
1,414
-3,785
| -73% | -$546K |
|
3721
PUT
T. Rowe Price
TROW
$24B
| $219K | ﹤0.01% |
+1,800
| New | +$213K |
|
3722
Delta Air Lines
DAL
$54.2B
| $217K | ﹤0.01% |
3,703
-293,784
| -99% | -$16.5M |
|
3723
United Rentals
URI
$67.4B
| $217K | ﹤0.01% |
1,302
-8,801
| -87% | -$1.28M |
|
3724
PUT
Synchrony
SYF
$26B
| $216K | ﹤0.01% |
+6,000
| New | +$215K |
|
3725
Gates Industrial Corp
GTES
$6.59B
| $215K | ﹤0.01% |
15,593
-23,930
| -61% | -$272K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.